0001062993-23-004232.txt : 20230221 0001062993-23-004232.hdr.sgml : 20230221 20230221162424 ACCESSION NUMBER: 0001062993-23-004232 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230216 FILED AS OF DATE: 20230221 DATE AS OF CHANGE: 20230221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Laing Lance G. CENTRAL INDEX KEY: 0001716041 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38207 FILM NUMBER: 23648555 MAIL ADDRESS: STREET 1: C/O CELCUITY, 16305 36TH AVENUE N. STREET 2: #450 CITY: MINNEAPOLIS STATE: MN ZIP: 55446 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celcuity Inc. CENTRAL INDEX KEY: 0001603454 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 16305 36TH AVENUE N STREET 2: SUITE 100 CITY: MINNEAPOLIS STATE: MN ZIP: 55446 BUSINESS PHONE: 763-392-0767 MAIL ADDRESS: STREET 1: 16305 36TH AVENUE N STREET 2: SUITE 100 CITY: MINNEAPOLIS STATE: MN ZIP: 55446 FORMER COMPANY: FORMER CONFORMED NAME: Celcuity LLC DATE OF NAME CHANGE: 20140324 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2023-02-16 0001603454 Celcuity Inc. CELC 0001716041 Laing Lance G. 16305 36TH AVENUE N. SUITE 100 MINNEAPOLIS MN 55446 1 1 1 0 Chief Science Officer Common Stock 1250000 D Stock Option (right to buy) 8.4000 2027-05-17 Common Stock 16125 16125 D Stock Option (right to buy) 5.50 2027-09-19 Common Stock 4110 4110 D Stock Option (right to buy) 5.50 2028-10-17 Common Stock 1834 1834 D Stock Option (right to buy) 5.50 2029-08-12 Common Stock 50000 50000 D Stock Option (right to buy) 5.9000 2030-08-12 Common Stock 20000 20000 D Stock Option (right to buy) 5.50 2030-12-28 Common Stock 2771 2771 D Stock Option (right to buy) 5.50 2031-02-02 Common Stock 3215 3215 D Stock Option (right to buy) 5.50 2031-03-18 Common Stock 2973 2973 D Stock Option (right to buy) 5.50 2031-04-12 Common Stock 6754 6754 D Stock Option (right to buy) 5.50 2031-08-11 Common Stock 20000 20000 D Stock Option (right to buy) 5.50 2031-10-27 Common Stock 1877 1877 D Stock Option (right to buy) 5.50 2032-05-17 Common Stock 38412 38412 D Stock Option (right to buy) 11.55 2023-02-16 4 A 0 9156 0 A 2033-02-16 Common Stock 9156 9156 D Fully vested. 12,500 shares vest on 8/12/20; the remaining 37,500 shares vest 1/36th per month thereafter. 5,000 shares vest on 8/12/21; the remaining 15,000 shares vest 1/36th per month thereafter. 692 shares vest on 12/29/21; the remaining 2,079 shares vest 1/36th per month thereafter. 803 shares vest on 2/2/22; the remaining 2,412 shares vest 1/36th per month thereafter. 743 shares vest on 3/18/22; the remaining 2,230 shares vest 1/36th per month thereafter. 1,689 shares vest on 4/12/22; the remaining 5,065 shares vest 1/36th per month thereafter. 5,000 shares vest on 8/11/22; the remaining 15,000 shares vest 1/36th per month thereafter. 469 shares vest on 10/27/22; the remaining 1,408 shares vest 1/36th per month thereafter. These shares vest in equal amounts over fourteen (14) months, beginning June 1, 2022. These shares vest in equal amounts over twelve (12) months, beginning February 16, 2023. /s/ Eric O. Madson as Attorney-in-Fact for Lance G. Laing pursuant to Power of Attorney previously filed. 2023-02-21